Global Oncology Biosimilars Market Status and Outlook 2018-2025

August 2018 | 136 pages | ID: G0D882F0148EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Celltrion Inc.
• Pfizer Inc.
• Biocon
• BIOCAD
• Apotex Inc.
• Dr. Reddy's
• Sandoz International GmbH
• Intas Pharmaceuticals Ltd.
• STADA Arzneimittel AG
• Teva Pharmaceutical Industries Ltd

Market by Type

• G-CSF
• Hematopoietic Agents
• Monoclonal Antibodies

Market by Application

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Oncology Biosimilars Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 G-CSF
  3.1.2 Hematopoietic Agents
  3.1.3 Monoclonal Antibodies
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Retail Pharmacies
  4.1.2 Hospital Pharmacies
  4.1.3 Online Pharmacies
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 G-CSF Production by Region
    6.1.1.2 Hematopoietic Agents Production by Region
    6.1.1.3 Monoclonal Antibodies Production by Region
  6.1.2 Production by Application
    6.1.2.1 Retail Pharmacies Production by Region
    6.1.2.2 Hospital Pharmacies Production by Region
    6.1.2.3 Online Pharmacies Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 G-CSF Demand by Region
    6.2.1.2 Hematopoietic Agents Demand by Region
    6.2.1.3 Monoclonal Antibodies Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Retail Pharmacies Demand by Region
    6.2.2.2 Hospital Pharmacies Demand by Region
    6.2.2.3 Online Pharmacies Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Celltrion Inc.
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Pfizer Inc.
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Biocon
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 BIOCAD
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Apotex Inc.
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Dr. Reddy's
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Sandoz International GmbH
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Intas Pharmaceuticals Ltd.
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 STADA Arzneimittel AG
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Teva Pharmaceutical Industries Ltd
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Oncology Biosimilars Industry Dynamics & Regulations List
Table Global Oncology Biosimilars Sales Revenue, Cost and Margin, 2015-2018E
Table Global Oncology Biosimilars Market Status by Type 2015-2018E, in USD Million
Table Global Oncology Biosimilars Market Status by Application 2015-2018E, in USD Million
Table Global Oncology Biosimilars Market Status by Application 2015-2018E, in Volume
Table Global Oncology Biosimilars Market by Region 2015-2018E, in USD Million
Table Global Oncology Biosimilars Market Share by Region in 2018, in USD Million
Table Global Oncology Biosimilars Market by Region 2015-2018E, in Volume
Table Global Oncology Biosimilars Market Share by Region in 2018, in Volume
Table G-CSF Production Value by Region 2015-2018E, in USD Million
Table G-CSF Production Volume by Region 2015-2018E, in Volume
Table Hematopoietic Agents Production Value by Region 2015-2018E, in USD Million
Table Hematopoietic Agents Production Volume by Region 2015-2018E, in Volume
Table Monoclonal Antibodies Production Value by Region 2015-2018E, in USD Million
Table Monoclonal Antibodies Production Volume by Region 2015-2018E, in Volume
Table Retail Pharmacies Production Value by Region 2015-2018E, in USD Million
Table Retail Pharmacies Production Volume by Region 2015-2018E, in Volume
Table Hospital Pharmacies Production Value by Region 2015-2018E, in USD Million
Table Hospital Pharmacies Production Volume by Region 2015-2018E, in Volume
Table Online Pharmacies Production Value by Region 2015-2018E, in USD Million
Table Online Pharmacies Production Volume by Region 2015-2018E, in Volume
Table G-CSF Market Size by Region 2015-2018E, in USD Million
Table G-CSF Market Size by Region 2015-2018E, in Volume
Table Hematopoietic Agents Market Size by Region 2015-2018E, in USD Million
Table Hematopoietic Agents Market Size by Region 2015-2018E, in Volume
Table Monoclonal Antibodies Market Size by Region 2015-2018E, in USD Million
Table Monoclonal Antibodies Market Size by Region 2015-2018E, in Volume
Table Retail Pharmacies Market Size by Region 2015-2018E, in USD Million
Table Retail Pharmacies Market Size by Region 2015-2018E, in Volume
Table Hospital Pharmacies Market Size by Region 2015-2018E, in USD Million
Table Hospital Pharmacies Market Size by Region 2015-2018E, in Volume
Table Online Pharmacies Market Size by Region 2015-2018E, in USD Million
Table Online Pharmacies Market Size by Region 2015-2018E, in Volume
Table GlobalOncology Biosimilars Forecast by Type 2019F-2025F, in USD Million
Table Oncology Biosimilars Forecast by Type 2019F-2025F, in Volume
Table Oncology Biosimilars Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Oncology Biosimilars Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Oncology Biosimilars Market Forecast by Region 2019F-2025F, in USD Million
Table Oncology Biosimilars Market Forecast by Region 2019F-2025F, in Volume
Table Celltrion Inc. Information
Table Oncology Biosimilars Sales, Cost, Margin of Celltrion Inc.
Table Pfizer Inc. Information
Table Oncology Biosimilars Sales, Cost, Margin of Pfizer Inc.
Table Biocon Information
Table Oncology Biosimilars Sales, Cost, Margin of Biocon
Table BIOCAD Information
Table Oncology Biosimilars Sales, Cost, Margin of BIOCAD
Table Apotex Inc. Information
Table Oncology Biosimilars Sales, Cost, Margin of Apotex Inc.
Table Dr. Reddy's Information
Table Oncology Biosimilars Sales, Cost, Margin of Dr. Reddy's
Table Sandoz International GmbH Information
Table Oncology Biosimilars Sales, Cost, Margin of Sandoz International GmbH
Table Intas Pharmaceuticals Ltd. Information
Table Oncology Biosimilars Sales, Cost, Margin of Intas Pharmaceuticals Ltd.
Table STADA Arzneimittel AG Information
Table Oncology Biosimilars Sales, Cost, Margin of STADA Arzneimittel AG
Table Teva Pharmaceutical Industries Ltd Information
Table Oncology Biosimilars Sales, Cost, Margin of Teva Pharmaceutical Industries Ltd
Table Global Oncology Biosimilars Sales Revenue by Company 2015-2017, in USD Million
Table Global Oncology Biosimilars Sales Volume by Company 2015-2017, in Volume
Table Global Oncology Biosimilars Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Oncology Biosimilars Picture
Figure Oncology Biosimilars Industry Chain Diagram
Figure Global Oncology Biosimilars Sales Revenue 2015-2018E, in USD Million
Figure Global Oncology Biosimilars Sales Volume 2015-2018E, in Volume
Figure Global Oncology Biosimilars Market Status by Type 2015-2018E, in Volume
Figure North America Oncology Biosimilars Market Size and Growth 2015-2018E, in USD Million
Figure North America Oncology Biosimilars Market Size and Growth 2015-2018E, in Volume
Figure Europe Oncology Biosimilars Market Size and Growth 2015-2018E, in USD Million
Figure Europe Oncology Biosimilars Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Oncology Biosimilars Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Oncology Biosimilars Market Size and Growth 2015-2018E, in Volume
Figure South America Oncology Biosimilars Market Size and Growth 2015-2018E, in USD Million
Figure South America Oncology Biosimilars Market Size and Growth 2015-2018E, in Volume
Figure Middle East Oncology Biosimilars Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Oncology Biosimilars Market Size and Growth 2015-2018E, in Volume
Figure Africa Oncology Biosimilars Market Size and Growth 2015-2018E, in USD Million
Figure Africa Oncology Biosimilars Market Size and Growth 2015-2018E, in Volume
Figure Global Oncology Biosimilars Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Oncology Biosimilars Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Oncology Biosimilars Sales Price Forecast 2019F-2025F
Figure Global Oncology Biosimilars Gross Margin Forecast 2019F-2025F
Figure Global Oncology Biosimilars Sales Revenue by Company in 2018, in USD Million
Figure Global Oncology Biosimilars Price by Company in 2018
Figure Global Oncology Biosimilars Gross Margin by Company in 2018